CI/CD integration, a dedicated "test farm" and a focus on innovative efficiency and automation solutions reduced certification times from the expected 12-18 months to 8 months
CI/CD integration, a dedicated "test farm" and a focus on innovative efficiency and automation solutions reduced certification times from the expected 12-18 months to 8 months
OSLO, Norway, July 3, 2025 /PRNewswire/ -- Norway-based browser developer, Opera , is breaking down language barriers for its users with the launch of...
EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe...
Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics’ proprietary OGAP®-Verify discovery platform
Tencent Cloud to extend its capabilities and expertise leveraging on its core ecosystem strengths in South Korea's gaming sector
HONG KONG, July 3, 2025 /PRNewswire/...
INDIANAPOLIS and DENVER, July 2, 2025 /PRNewswire/ -- After 4 years in development, Lore Link is now publicly available as an online management tool...
HONG KONG, July 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and AI to redefine...
DENVER, July 02, 2025 (GLOBE NEWSWIRE) -- Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has received confirmation from The Nasdaq Stock Market that the Company has evidenced compliance with the minimum $2.5 million stockholders’ equity requirement and all other applicable criteria for continued listing on The Nasdaq Capital Market. Accordingly, the previously disclosed listing matter has been closed.
PLYMOUTH MEETING, Pa., July 2, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to...
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.
LEEDS, England, July 2, 2025 /PRNewswire/ -- Build Concierge, the customer engagement platform, has raised $5.1m (£3.8m) in seed funding from a consortium of...
Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.
Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.